Amphastar Pharmaceuticals Inc
AMPH29.260USD
+0.630+2.20%
終値 02/06, 16:00（ET）15分遅れの株価
1.36B時価総額
12.41直近12ヶ月PER
詳細情報 Amphastar Pharmaceuticals Inc 企業名
Amphastar Pharmaceuticals, Inc. is a biopharmaceutical company that focuses primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable, inhalation, and intranasal products. Additionally, it sells insulin API products. Most of its finished products are used in hospital or urgent care clinical settings and are primarily contracted and distributed through group purchasing organizations and drug wholesalers. The Company manufactures and sells over 25 products, such as BAQSIMI (glucagon) nasal powder 3mg, Primatene MIST, Glucagon for Injection Emergency Kit, Enoxaparin, Naloxone and Other Marketed Products, including Cortrosyn (cosyntropin for injection), Amphadase, Epinephrine injection, Lidocaine jelly, Lidocaine topical solution, Phytonadione injection, and others. The Company manufactures and sells two API products, Recombinant Human Insulin (RHI API) and porcine insulin API, for the injectable insulin market.
Amphastar Pharmaceuticals Incの企業情報
企業コードAMPH
会社名Amphastar Pharmaceuticals Inc
上場日Jun 25, 2014
最高経営責任者「CEO」Zhang (Yongfeng Yongfeng)
従業員数2028
証券種類Ordinary Share
決算期末Jun 25
本社所在地11570 6th St
都市RANCHO CUCAMONGA
証券取引所NASDAQ OMX - NASDAQ BASIC
国United States of America
郵便番号91730
電話番号19099809484
ウェブサイトhttps://amphastar.com/
企業コードAMPH
上場日Jun 25, 2014
最高経営責任者「CEO」Zhang (Yongfeng Yongfeng)
Amphastar Pharmaceuticals Incの経営陣
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Rong Zhou
Mr. Rong Zhou
Senior Executive Vice President of Production Center, Executive Vice President of Scientific Affairs, President of Amphastar Nanjing Pharmaceuticals, Co., Ltd.
Senior Executive Vice President of Production Center, Executive Vice President of Scientific Affairs, President of Amphastar Nanjing Pharmaceuticals, Co., Ltd.
197.10K
--
Dr. Howard S. Lee, Ph.D.
Dr. Howard S. Lee, Ph.D.
Independent Director
Independent Director
148.90K
+4199.00%
Mr. Floyd F. Petersen
Mr. Floyd F. Petersen
Independent Director
Independent Director
68.29K
-4163.00%
Mr. William J. Peters
Mr. William J. Peters
Chief Financial Officer, Executive Vice President - Finance, Treasurer, President of International Medication Systems Limited, Director
Chief Financial Officer, Executive Vice President - Finance, Treasurer, President of International Medication Systems Limited, Director
55.44K
-273.00%
Mr. Richard K. Prins
Mr. Richard K. Prins
Lead Independent Director
Lead Independent Director
32.11K
--
Ms. Gayle Deflin
Ms. Gayle Deflin
Independent Director
Independent Director
7.84K
+5122.00%
Dr. Yongfeng (Jack) Zhang, Ph.D.
Dr. Yongfeng (Jack) Zhang, Ph.D.
President, Chief Executive Officer, Chief Scientific Officer, Director
President, Chief Executive Officer, Chief Scientific Officer, Director
--
--
Dr. Ziping (Mary) Luo, Ph.D.
Dr. Ziping (Mary) Luo, Ph.D.
Chairman of the Board, Chief Operating Officer, Chief Scientist
Chairman of the Board, Chief Operating Officer, Chief Scientist
--
--
Ms. Diane G. Gerst
Ms. Diane G. Gerst
Independent Director
Independent Director
--
--
Dr. Michael A. Zasloff, M.D., Ph.D.
Dr. Michael A. Zasloff, M.D., Ph.D.
Independent Director
Independent Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Rong Zhou
Mr. Rong Zhou
Senior Executive Vice President of Production Center, Executive Vice President of Scientific Affairs, President of Amphastar Nanjing Pharmaceuticals, Co., Ltd.
Senior Executive Vice President of Production Center, Executive Vice President of Scientific Affairs, President of Amphastar Nanjing Pharmaceuticals, Co., Ltd.
197.10K
--
Dr. Howard S. Lee, Ph.D.
Dr. Howard S. Lee, Ph.D.
Independent Director
Independent Director
148.90K
+4199.00%
Mr. Floyd F. Petersen
Mr. Floyd F. Petersen
Independent Director
Independent Director
68.29K
-4163.00%
Mr. William J. Peters
Mr. William J. Peters
Chief Financial Officer, Executive Vice President - Finance, Treasurer, President of International Medication Systems Limited, Director
Chief Financial Officer, Executive Vice President - Finance, Treasurer, President of International Medication Systems Limited, Director
55.44K
-273.00%
Mr. Richard K. Prins
Mr. Richard K. Prins
Lead Independent Director
Lead Independent Director
32.11K
--
Ms. Gayle Deflin
Ms. Gayle Deflin
Independent Director
Independent Director
7.84K
+5122.00%
収益内訳
通貨: USD更新時刻: Tue, Jan 6
通貨: USD更新時刻: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
会社から関連データがまだ開示されていません。
地域別USD
会社名
収益
比率
United States
180.28M
93.97%
France
9.68M
5.05%
China
1.88M
0.98%
事業別
地域別
会社から関連データがまだ開示されていません。
株主
更新時刻: Sun, Nov 16
更新時刻: Sun, Nov 16
株主統計
種類
株主統計
株主統計
比率
Applied Physics & Chemistry Laboratories, Inc.
14.86%
BlackRock Institutional Trust Company, N.A.
10.75%
Zhang (Jack Yongfeng)
5.71%
The Vanguard Group, Inc.
5.63%
TD Asset Management Inc.
4.20%
他の
58.85%
株主統計
株主統計
比率
Applied Physics & Chemistry Laboratories, Inc.
14.86%
BlackRock Institutional Trust Company, N.A.
10.75%
Zhang (Jack Yongfeng)
5.71%
The Vanguard Group, Inc.
5.63%
TD Asset Management Inc.
4.20%
他の
58.85%
種類
株主統計
比率
Investment Advisor
40.25%
Investment Advisor/Hedge Fund
22.89%
Corporation
14.86%
Individual Investor
9.43%
Hedge Fund
6.46%
Research Firm
2.82%
Pension Fund
1.05%
Bank and Trust
0.31%
Family Office
0.28%
他の
1.65%
機関投資家保有株
更新時刻: Mon, Dec 8
更新時刻: Mon, Dec 8
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q4
586
33.97M
85.20%
+16.67K
2025Q3
603
33.96M
84.80%
+202.84K
2025Q2
607
33.74M
83.87%
-544.61K
2025Q1
597
34.53M
80.40%
-3.80M
2024Q4
593
35.69M
79.40%
-112.11K
2024Q3
575
35.68M
75.48%
+965.70K
2024Q2
565
34.64M
73.86%
+833.26K
2024Q1
548
33.97M
73.49%
-1.92M
2023Q4
531
33.91M
72.12%
+1.03M
2023Q3
499
32.97M
71.03%
+509.94K
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Applied Physics & Chemistry Laboratories, Inc.
6.83M
14.86%
--
--
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
4.94M
10.75%
-185.58K
-3.62%
Sep 30, 2025
Zhang (Jack Yongfeng)
2.62M
5.71%
+200.00K
+8.25%
Jun 13, 2025
The Vanguard Group, Inc.
2.61M
5.68%
-55.91K
-2.10%
Sep 30, 2025
TD Asset Management Inc.
1.93M
4.2%
-103.04K
-5.06%
Sep 30, 2025
Dimensional Fund Advisors, L.P.
1.76M
3.82%
+128.78K
+7.92%
Sep 30, 2025
State Street Investment Management (US)
1.50M
3.27%
-75.49K
-4.79%
Sep 30, 2025
Fuller & Thaler Asset Management Inc.
1.35M
2.95%
+90.16K
+7.13%
Sep 30, 2025
Epoch Investment Partners, Inc.
1.13M
2.47%
-107.38K
-8.65%
Sep 30, 2025
Luo (Mary Z)
1.09M
2.37%
+69.40K
+6.79%
Mar 31, 2025
詳細を見る
関連ETF
更新時刻: Sat, Dec 6
更新時刻: Sat, Dec 6
銘柄名
比率
Invesco Pharmaceuticals ETF
2.25%
State Street SPDR S&P Pharmaceuticals ETF
1.47%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
1.38%
Invesco S&P SmallCap 600 GARP ETF
1.12%
Acquirers Small and Micro Deep Value ETF
0.87%
Pacer US Small Cap Cash Cows Growth Leaders ETF
0.77%
Invesco S&P SmallCap Health Care ETF
0.56%
First Trust Small Cap Value AlphaDEX Fund
0.5%
Distillate Small/Mid Cash Flow ETF
0.45%
VictoryShares Small Cap Free Cash Flow ETF
0.37%
詳細を見る
Invesco Pharmaceuticals ETF
比率2.25%
State Street SPDR S&P Pharmaceuticals ETF
比率1.47%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
比率1.38%
Invesco S&P SmallCap 600 GARP ETF
比率1.12%
Acquirers Small and Micro Deep Value ETF
比率0.87%
Pacer US Small Cap Cash Cows Growth Leaders ETF
比率0.77%
Invesco S&P SmallCap Health Care ETF
比率0.56%
First Trust Small Cap Value AlphaDEX Fund
比率0.5%
Distillate Small/Mid Cash Flow ETF
比率0.45%
VictoryShares Small Cap Free Cash Flow ETF
比率0.37%
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
配当落ち日
種類
比率
データなし
日付
配当落ち日
種類
比率
データなし
